Table 1.
The molecule name (MolName), CAS, molecule weight (MW, g/mol), calculated binding energies (ΔGADV, kcal/mol), and BLI binding kinetics (KD, kon, kdis, and R2) of compounds selected from primary in vitro binding screen.
No. | Mol. name | CAS | MW | ΔGADV | KD (μmol/L) | kon (L/(mol·s)) | kdis (1/s) | Full R2 |
---|---|---|---|---|---|---|---|---|
1 | Pazopanib | 444731-52-6 | 437.5 | −9.2 | N.D.a | N.D. | N.D. | N.D. |
11 | Verbascoside | 61276-17-3 | 624.6 | −8.3 | 0.84 ± 0.85 | 108 | 9.05×10−5 | 98% |
19 | Zafirlukast | 107753-78-6 | 575.7 | −9.5 | >1000 | 8.43 | 4.99 | 87% |
21 | Paliperidone | 144598-75-4 | 426.5 | −8.6 | N.D. | N.D. | N.D. | N.D. |
25 | Pictilisib | 957054-30-7 | 513.6 | −8.7 | N.D. | N.D. | N.D. | N.D. |
27 | steviolbioside | 41093-60-1 | 642.7 | −9.4 | N.D. | N.D. | N.D. | N.D. |
34 | COH29 | 1190932-38-7 | 420.4 | −8.5 | >1000 | 8.10 | 0.189 | 87% |
35 | Oleanonic Acid | 17990-42-0 | 454.7 | −9.6 | 171.00 ± 35.90 | 98.4 | 1.68×10−2 | 84% |
36 | Forsythoside A | 79916-77-1 | 624.6 | −8.7 | 1.16 ± 0.44 | 137 | 1.59×10−4 | 99% |
37 | Corilagin | 23094-69-1 | 634.5 | −8.9 | 0.54 ± 0.01 | 496 | 2.68×10−4 | 97% |
38 | Ligustroflavone | 260413-62-5 | 724.7 | −10.1 | N.D. | N.D. | N.D. | N.D. |
40 | Ledipasviracetone | 1441674-54-9 | 947.1 | −9.5 | N.D. | N.D. | N.D. | N.D. |
44 | Narirutin | 14259-46-2 | 580.5 | −9.0 | N.D. | N.D. | N.D. | N.D. |
45 | MK-3903 | 1219737-12-8 | 454.9 | −8.9 | 220.00 ± 19.40 | 302 | 6.65×10−2 | 96% |
47 | T-5224 | 530141-72-1 | 517.5 | −8.6 | 38.70 ± 1.63 | 200 | 7.74×10−3 | 98% |
50 | AMG-900 | 945595-80-2 | 503.6 | −9.1 | N.D. | N.D. | N.D. | N.D. |
N.D. = not detected.